Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Selective Depletion of C-reactive Protein by Therapeutic Apheresis (CRP Apheresis) After Elective Primary Coronary Bypass Surgery

NCT04745468 is registered in ClinicalTrials.gov with Pentracor GmbH as lead sponsor.

NCT NCT04745468
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04745468 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Selective Depletion of C-reactive Protein by Therapeutic Apheresis (CRP Apheresis) After Elective Primary Coronary Bypass Surgery
Lead sponsor
Pentracor GmbH
Phase
Not applicable
Overall status
Completed
Start date
March 21, 2018
Completion date
January 28, 2021
Enrollment
37 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-cardiac surgery